Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12576063 | Implantable drug delivery devices for localized drug delivery | 🖼🧊📄§ | 2026-03-17 | 2040-12-18 | 0 | 31 |
| 12576111 | Application of BMSC-exos in treating PD | 🖼🧊📄§ | 2026-03-17 | 2042-10-19 | 0 | 31 |
| 12576152 | Topical composition | 🖼🧊📄§ | 2026-03-17 | 2045-06-27 | 0 | 31 |
| 12577249 | GCN2 and perk kinase inhibitors and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2042-12-02 | 0 | 31 |
| 12576122 | Combination therapy for cancer | 🖼🧊📄§ | 2026-03-17 | 2039-02-11 | 0 | 31 |
| 12576110 | Methods and compositions for reconstituting microglia | 🖼🧊📄§ | 2026-03-17 | 2040-08-06 | 0 | 31 |
| 12576104 | Dental preparation comprising fibers based on hyaluronic acid with regulated biodegradability | 🖼🧊📄§ | 2026-03-17 | 2041-01-05 | 0 | 31 |
| 12577312 | Methods for the treatment of melanoma using compositions of denosumab and PD-1 inhibitor | 🖼🧊📄§ | 2026-03-17 | 2045-02-26 | 0 | 31 |
| 12576098 | Saponin containing extracts prepared from Hesperaloe useful in the treatment of non-human animals | 🖼🧊📄§ | 2026-03-17 | 2041-06-21 | 0 | 31 |
| 12576070 | Medicine for improving state of pregnancy, and use thereof | 🖼🧊📄§ | 2026-03-17 | 2042-11-23 | 0 | 31 |
| 12576088 | Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B | 🖼🧊📄§ | 2026-03-17 | 2043-09-15 | 0 | 31 |
| 12576062 | Methods using administration of medium chain triglycerides (MCT) prior to a meal to increase ketone production from the MCTs | 🖼🧊📄§ | 2026-03-17 | 2040-03-17 | 0 | 31 |
| 12576042 | Methods and compositions for treating neurological conditions | 🖼🧊📄§ | 2026-03-17 | 2042-12-02 | 0 | 31 |
| 12577291 | Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases | 🖼🧊📄§ | 2026-03-17 | 2042-11-22 | 0 | 31 |
| 12576069 | Compositions and methods for treating slow-flow vascular malformations | 🖼🧊📄§ | 2026-03-17 | 2040-09-10 | 0 | 31 |
| 12576044 | Treatment of Alzheimer's disease | 🖼🧊📄§ | 2026-03-17 | 2043-05-03 | 0 | 31 |
| 12576158 | Antibody drug conjugates with cleavable linkers | 🖼🧊📄§ | 2026-03-17 | 2040-05-22 | 0 | 31 |
| 12576128 | Genetically engineered microorganisms and methods of use | 🖼🧊📄§ | 2026-03-17 | 2040-05-01 | 0 | 31 |
| 12577292 | Ferritin nanocage for multi-displaying trail trimer and cancer-targeting peptide and use thereof as anticancer agent | 🖼🧊📄§ | 2026-03-17 | 2040-03-06 | 0 | 31 |
| 12576123 | Epitope-based approach for allergy treatments and inhibitors for Crohn's disease | 🖼🧊📄§ | 2026-03-17 | 2040-03-13 | 0 | 31 |
| 12577238 | Compositions and methods for modulating inflammatory and degenerative disorder | 🖼🧊📄§ | 2026-03-17 | 2042-08-17 | 0 | 31 |
| 12576109 | Allogeneic human plasma and platelet derived products and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2045-04-30 | 0 | 31 |
| 12577231 | Androgen receptor PROTACS | 🖼🧊📄§ | 2026-03-17 | 2045-06-30 | 0 | 31 |
| 12576048 | Anti-cancer activity of adamantane derivatives | 🖼🧊📄§ | 2026-03-17 | 2039-12-05 | 0 | 31 |
| 12577267 | Pyrimidine compounds for use as MAP4K1 inhibitors | 🖼🧊📄§ | 2026-03-17 | 2042-07-06 | 0 | 31 |
| 12576105 | Compositions for treating joint or connective tissue disease comprising dextran or poloxamer | 🖼🧊📄§ | 2026-03-17 | 2043-10-05 | 0 | 31 |
| 12576074 | Kits and methods for induction of cardioversion in subjects with atrial arrhythmias | 🖼🧊📄§ | 2026-03-17 | 2043-03-20 | 0 | 31 |
| 12576073 | Antiarrhythmic formulation | 🖼🧊📄§ | 2026-03-17 | 2042-01-13 | 0 | 31 |
| 12576047 | Telomerase activating compounds for use in fertility and related applications | 🖼🧊📄§ | 2026-03-17 | 2043-08-25 | 0 | 31 |
| 12576107 | Methods of treating chronic inflammatory diseases | 🖼🧊📄§ | 2026-03-17 | 2043-09-11 | 0 | 31 |
| 12577287 | T cell receptors and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-03-24 | 0 | 31 |
| 12577246 | Indoline compound | 🖼🧊📄§ | 2026-03-17 | 2042-02-08 | 0 | 31 |
| 12577303 | SIRPα-targeting antibody or antigen binding fragment thereof, and preparation and application thereof | 🖼🧊📄§ | 2026-03-17 | 2041-03-17 | 0 | 31 |
| 12577323 | Compositions and conjugates comprising an interleukin and polypeptides that specifically bind TGF-beta | 🖼🧊📄§ | 2026-03-17 | 2036-06-08 | 0 | 31 |
| 12576055 | Disease detection and treatment based on trimethyl-lysine levels | 🖼🧊📄§ | 2026-03-17 | 2039-02-01 | 0 | 31 |
| 12576116 | Use of probiotics in the treatment and/or prevention of atopic dermatitis | 🖼🧊📄§ | 2026-03-17 | 2037-07-18 | 0 | 31 |
| 12577254 | Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors | 🖼🧊📄§ | 2026-03-17 | 2043-08-18 | 0 | 31 |
| 12577314 | Anti-BCMA/anti-4-1BB bispecific antibodies and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2040-12-10 | 0 | 31 |
| 12576121 | Acacia nilotica based hydrogel and method of making the same | 🖼🧊📄§ | 2026-03-17 | 2045-12-12 | 0 | 31 |
| 12576138 | Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase | 🖼🧊📄§ | 2026-03-17 | 2039-05-17 | 0 | 31 |
| 12577301 | GRP78-binding antibodies and use thereof in detecting or neutralizing GRP78 | 🖼🧊📄§ | 2026-03-17 | 2044-07-12 | 0 | 31 |
| 12576120 | Antiproliferative effect of agarophyton chilensis extract in prostate cancer | 🖼🧊📄§ | 2026-03-17 | 2039-06-28 | 0 | 31 |
| 12576118 | Bacteriophages for the treatment of tuberculosis | 🖼🧊📄§ | 2026-03-17 | 2040-05-21 | 0 | 31 |
| 12576159 | Anti-human PD-1 antibody crystals and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2039-10-28 | 0 | 31 |
| 12576053 | Use of 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl) methylidenejinden-1-yl] acetic acid | 🖼🧊📄§ | 2026-03-17 | 2038-04-11 | 0 | 31 |
| 12577307 | Method and medicament for treating cancer unresponsive to PD-1/PD-L1 signaling inhibitor | 🖼🧊📄§ | 2026-03-17 | 2039-10-17 | 0 | 31 |
| 12576136 | Insulin derivative | 🖼🧊📄§ | 2026-03-17 | 2040-12-29 | 0 | 31 |
| 12576155 | Senolytic and antiinflammatory prodrugs and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-09-24 | 0 | 31 |
| 12577281 | Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer | 🖼🧊📄§ | 2026-03-17 | 2041-05-14 | 0 | 31 |
| 12577311 | Chimeric antigen receptor factories and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2039-12-02 | 0 | 31 |